Related Experiment Videos
[TNFalpha inhibitors for the treatment of rheumatoid arthritis]
Jacques Sany1, Marie-Joëlle Kaiser
1Service d'Immuno-Rhumatologie, Hôpital Lapeyronie, CHU, 371, avenue du Doyen-Gaston-Giraud, 34295 Montpellier Cedex 5, France. j-sany@chu-montpellier.fr
Annales De Medecine Interne
|May 8, 2002
Abstract:
Reasons for using TNFalpha inhibitors in rheumatoid arthritis Available agents modulating TNFalpha Adverse effects to TNFalpha inhibitors Which patients should be treated with TNFalpha inhibitors? Monitoring treatment with TNFalpha inhibitors Patient follow-up Open questions Conclusions